Pacific Biosciences Of California (PACB) Inventory Average (2011 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Inventory Average of $50.2 million for Q1 2026, down 11.05% year-over-year from $56.4 million in Q1 2025, and down 2.08% quarter-over-quarter from $51.2 million in Q4 2025.
Pacific Biosciences Of California (PACB) Inventory Average (2011 - 2026) Analysis & Trends
Pacific Biosciences Of California's Inventory Average history runs 16 years deep, the most recent figure standing at $50.2 million for Q1 2026.
- In Q1 2026, Inventory Average fell 11.05% year-over-year to $50.2 million; the TTM figure through Mar 2026 stood at $50.2 million (down 11.05% YoY), while the FY2025 annual figure was $54.0 million, down 6.4% from the prior year.
- Inventory Average for Q1 2026 stood at $50.2 million, down from $51.2 million in the prior quarter.
- The five-year high for Inventory Average was $68.0 million in Q2 2024, with the low at $27.1 million in Q1 2022.
- The 5-year median for Inventory Average is $56.2 million (2023), against an average of $54.3 million.
- The sharpest annual moves came in 2023 and 2025: Inventory Average jumped 107.17% in 2023, then retreated 20.66% in 2025.
- Pacific Biosciences Of California's Inventory Average stood at $46.9 million in 2022, then surged by 33.08% to $62.5 million in 2023, then decreased by 0.35% to $62.2 million in 2024, then dropped by 17.72% to $51.2 million in 2025, then retreated by 2.08% to $50.2 million in 2026.
- Business Quant data shows PACB's Inventory Average at $50.2 million in Q1 2026, $51.2 million in Q4 2025, and $53.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 7.15 Bn |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 5.47 Bn |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 6.13 Bn |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 3.18 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 1.13 Bn |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 710.00 Mn |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 2.42 Bn |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 3.69 Bn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 671.95 Mn |
| 10 | Pacific Biosciences Of California | 397.95 Mn | 161.08 Mn | 12.64 Mn | 56.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 56.05 Mn |
| Mar 31, 2026 | 50.15 Mn |
| Dec 31, 2025 | 51.22 Mn |
| Sep 30, 2025 | 53.50 Mn |
| Jun 30, 2025 | 53.92 Mn |
| Mar 31, 2025 | 56.38 Mn |
| Dec 31, 2024 | 62.25 Mn |
| Sep 30, 2024 | 67.17 Mn |
| Jun 30, 2024 | 67.97 Mn |
| Mar 31, 2024 | 62.01 Mn |
| Dec 31, 2023 | 62.47 Mn |
| Sep 30, 2023 | 67.93 Mn |
| Jun 30, 2023 | 64.78 Mn |
| Mar 31, 2023 | 56.17 Mn |
| Dec 31, 2022 | 46.94 Mn |
| Sep 30, 2022 | 39.81 Mn |
| Jun 30, 2022 | 32.87 Mn |
| Mar 31, 2022 | 27.11 Mn |
| Jun 30, 2021 | 17.13 Mn |
| Mar 31, 2021 | 15.25 Mn |